I-Mab (IMAB.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct29

Innovent Bio renamed as NovaBridge Biosciences and listed

20:08

Oct28

Inmabridge Completes Acquisition of Bridge Health Biotechnology

20:47

Oct27

Analyst Reiterates Buy Rating on I-Mab

10:32

Oct24

I-Mab Announces Positive I Phase Clinical Data for Givastomig in Advanced Gastric Cancer

17:02

Analyst Zelin covers JmBiopharma and other healthcare stocks

11:56

Oct22

Jennerex to Present Latest Phase 1 Data of Givastomig at AACR-NCI-EORTC

16:36

Schedules & Filings

Schedules

Filings

Oct30

Ticker Change(EST)

From 10.30 changed to NBP

Aug20

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -5.504 M, EPS -0.0673

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.15 M, EPS -0.0386

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More